title: Complete resection of the caudate lobe of the liver with tumor: technique and experience.
abstract: OBJECTIVE
  To study the technique and curative effects of complete resection of the caudate lobe of the liver with tumors.
  
  
  METHODS
  There were 18 patients with tumors in the caudate lobe of the liver in this study. Among them, hepatocellular carcinoma was found in 12 patients, metastasis to the caudate lobe two years after resection of rectal carcinoma in one, cholangiocarcinoma in one, and huge benign tumor in four. Complete caudate lobectomy and combined with left lateral lobectomy or left hemihepatectomy or left trilobectomy were performed in this series.
  
  
  RESULTS
  The median operating time was 227 min and median blood loss was 1590 mL, and the median blood transfusion was 1520 mL. No operative or postoperative mortality, or any postoperative complications were found in any of the patients. The 1-, 3- and 5-year survival rates of the 12 patients with hepatocellular carcinoma were 58.3%, 55.5% and 37.8%, respectively. One patient with cholangiocarcinoma died in postoperative 4 months. One patient with metastatic rectal cancer has been alive for more than 5 years after the operation, and 4 patients with benign tumors are still alive and well.
  
  
  CONCLUSIONS
  Complete resection of the caudate lobe of the liver should be the first choice for removal of huge tumors originating from the caudate lobe, although this procedure is quite difficult and has a high risk factor.
authors.affiliation: Liver Cancer Institute, Zhongshan Hospital, Shanghai Medical University, 136 Yi Xue Yuan Road, Shanghai, 200032 P.R. China. jiafan99@yahoo.com
authors.forename: J
authors.initials: J
authors.lastname: Fan
authors.forename: Z Q
authors.initials: ZQ
authors.lastname: Wu
authors.forename: Z Y
authors.initials: ZY
authors.lastname: Tang
authors.forename: J
authors.initials: J
authors.lastname: Zhou
authors.forename: S J
authors.initials: SJ
authors.lastname: Qiu
authors.forename: Z C
authors.initials: ZC
authors.lastname: Ma
authors.forename: X D
authors.initials: XD
authors.lastname: Zhou
authors.forename: Y Q
authors.initials: YQ
authors.lastname: Yu
mesh_terms: D000328:Adult; D000368:Aged; D001650:Bile Duct Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D001653:Bile Ducts, Intrahepatic / Q000473:pathology / Q000601:surgery*; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D002423:Cause of Death; D018281:Cholangiocarcinoma / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006498:Hepatectomy / Q000379:methods*; D006801:Humans; D008099:Liver / Q000473:pathology; D008113:Liver Neoplasms / Q000401:mortality / Q000473:pathology / Q000556:secondary / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011183:Postoperative Complications / Q000401:mortality; D012004:Rectal Neoplasms / Q000401:mortality / Q000601:surgery*; D015996:Survival Rate